Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02676986
Title Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer (ARB)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Queen Mary University of London
Indications

triple-receptor negative breast cancer

estrogen-receptor positive breast cancer

Therapies

Enzalutamide + Exemestane

Exemestane

Enzalutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.